Management of muscle-invasive bladder cancer: An update

Nature Clinical Practice Urology

Volumn 5, Issue 9, 2008, Pages 501-508

  Ghoneim, Mohamed A ^a   Abol Enein, Hassan ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

4F BTE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BCG VACCINE; CETUXIMAB; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CISPLATIN; DOXORUBICIN; GEMCITABINE; METHOTREXATE; TAXANE DERIVATIVE; TRASTUZUMAB; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VINBLASTINE;

ADJUVANT THERAPY; BLADDER CANCER; CANCER RELAPSE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COST EFFECTIVENESS ANALYSIS; CYSTECTOMY; DISEASE FREE SURVIVAL; DRUG MECHANISM; GENE TARGETING; HADRON; HUMAN; LYMPH NODE DISSECTION; MONOTHERAPY; MUSCLE INVASIVE BLADDER CANCER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURGICAL TECHNIQUE;

CYSTECTOMY; DISEASE MANAGEMENT; HUMANS; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 51549106075     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1202     Document Type: Review

References (57)

1. Pagano F et al. (1991) Results of contemporary radical cystectomy for invasive bladder cancer: A clinico pathological study with an emphasis on the inadequacy of the tumour, nodes and metastasis classification. J Urol 145: 45-50
2. Frazier HA et al. (1993) The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 71: 3993-4001
3. Ghoneim MA et al. (1997) Radical cystectomy for carcinoma of the bladder: Critical evaluation of the results in 1026 cases. J Urol 158: 393-399
4. Dalbagni G et al. (2001) Cystectomy for bladder cancer: A contemporary series. J Urol 165:1111-1116
5. Madersbacher S et al. (2003) Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J Clin Oncol 15: 690-696
6. Quek ML et al. (2005) Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 174: 103-107
7. Hautmann RE et al. (2006) Cystectomy for transitional cell carcinoma of the bladder results of a surgery-only series in the neobladder era. J Urol 176:486-492
8. Stein JP and Skinner DJ (2003) Results with radical cystectomy for treating bladder cancer: A reference standard for high grade, invasive bladder cancer. BJU Int 92: 12-17
9. Chang SS et al. (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170: 1085-1087
10. Sanchez-Ortiz RF et al. (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169: 110-115
11. Mohmud SM et al. (2006) Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: A population based study. J Urol 175: 78-83
12. Lee CT et al. (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175:1262-1267
13. Liedberg F et al. (2005) Treatment delay and prognosis in invasive bladder cancer. J Urol 174: 1717-1781
14. Leissner J et al. (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85: 817-823
15. Mills RD et al. (2001) Pelvic lymph-node metastases from bladder cancer: Outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166: 19-23
16. Stein JP et al. (2003) Risk factors for patients with pelvic node metastases following radical cystectomy with en block pelvic lymphadenectomy: The concept of lymph node density. J Urol 170 35-41
17. Herr HW (2003) Superiority of ratio based lymph node staging for bladder cancer. J Urol 169: 943-945
18. Vazina A et al. (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171: 1830-1834
19. Abdel-Latif M et al. (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: Incidence and prognosis. J Urol 172: 85-89
20. Kassouf W et al. (2006) Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176: 53-57
21. Abol-Enein H et al. (2004) Lymph node involvement in bladder cancer patients treated by radical cystectomy: A patho-anatomic study; a single center experience. J Urol 172: 1818-1821
22. Vieweg J et al. (1999) Pelvic lymph node dissection can be curative in patients with node positive bladder cancer. J Urol 161: 449-454
23. Weingartner K et al. (1996) Anatomical basis for pelvic lymphadenectomy in prostate cancer: Results of an autopsy study and implications for the clinic. J Urol 156: 1969-1971
24. Deserno WLG et al. (2004) Urinary bladder cancer: Preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 233: 449-455
25. Wallace DM and Bloom HJG (1976) The management of deeply infiltrating (T3) bladder carcinoma: Controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy. Br J Urol 48 587
26. Miller LS (1977) Bladder cancer: Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C. Cancer 39: 973-980
27. Whitmore WF et al. (1977) Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J Urol 118: 184-187
28. Droller MJ (1983) The controversial role of radiation therapy as adjunctive treatment of bladder cancer. J Urol 129: 897-903
29. Orecchia R et al. (2004) Clinical and research validity of hadrontherapy with ion bearns. Crit Rev Oncol Hematol 51: 81-90
30. Grossman HB et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349: 859-866
31. Herr HW et al. (2004) Surgical factors influence bladder cancer outcome: A cooperative group report J Clin Oncol 22: 2781-2789
32. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Neo-adjuvant chemotherapy in invasive bladder cancer: Update of a systematic review and meta-analysis of individual patients data. Eur Urol 48: 202-206
33. Slefker-Radtke A et al. (2004) Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder. a retrospective review of the M.D. Anderson cancer experience. J Urol 172: 481-484
34. Skinner DG et al. (1991) The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: A prospective comparative trial. J Urol 145: 459-467
35. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration (2005) Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data. Eur Urol 48: 189-201
36. Stokle M et al. (1995) Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): Improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol 153: 47-52
37. Freiha FS et al. (1996) A randomized trial of radical cystectomy plus cisplatin, vinblastin and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 155: 1241-1245
38. Rosenberg JE et al. (2005) Update on chemotherapy for advanced bladder cancer. J Urol 174: 14-20
39. Schoenberg MP et al. (1996) Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year follow up. J Urol 155: 490-494
40. Pritchett TR et al. (1988) The portency-sparing radical cystectomy: Does it compromise the completeness of the cancer resection? J Urol 140: 1400-1403
41. Kessler TM et al. (2005) Clinical indications and outcome with nerve-sparing cystectomy in patients with bladder cancer. Urol Clin N Am 32: 165-175
42. Hautmann RE and Stein JP (2005) Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: A step in the wrong direction. Urol Clin N Am 32: 177-185
43. Chang SS et al. (2002) Pathological findings of gynecologic organs obtained at female radical cystectomy. J Urol 168: 147-149
44. Ali-El-Dein B et al. (2004) Secondary malignant involvement of gynaecologic organs in radical cystectomy specimens in women: Is it mandatory to remove these organs routinely? J Urol 172: 885-887
45. Sanchez de Badajoz E et al. (1995) Laparoscopic cystectomy and ileal conduit: Case report. J Endourol 9: 59-62
46. Menon M et al. (2003) Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int 92: 232-236
47. Turk I et al. (2001) Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intra-corporeally: The initial 5 cases. J Urol 165: 1863-1866
48. Prie L et al. (1998) Conservative treatment of infiltrating cancer of the bladder: Neoadjuvant chemotherapy and radiotherapy. Cancer Radiother Suppl 1: 62-66
49. Shipley WU et al. (2002) Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasilve bladder cancer. Urology 60: 62-67
50. Rodel C et al. (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: Long-term results. J Clin Oncol 20: 3061-3071
51. De Crevoisler R et al. (2004) Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: Results of a 28-year single institution experience. Radlother Oncol 72: 147-157
52. Nieuwentuijzen JA et al. (2005) Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol 48: 239-245
53. Zietmann AL et al. (2003) Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: Results of a urodynamic and quality of life study on long-term survivors. J Urol 170: 1772-1776
54. Herr HW et al. (1999) Can p53 help select patients with invasive bladder cancer for bladder preservation? J Urol 161: 20-23
55. Bellmunt J et al. (2003) Novel approaches with target therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family. Crit Rev Oncol Hematol 46 (Suppl): S85-S104
56. Retz M et al. (2005) New HIV-Drug inhibits in vitro bladder cancer migration and invasion. Eur Urol 48: 1025-1030
57. Duggan BJ et al. (2002) The role of antisense oligonucleotides in the treatment of bladder cancer. Urol Res 30: 137-147